Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies

The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Biologics Evaluation and Research (CBER) requirement for baboons for studies to be conducted at FDA/CBER Facility in Silver Spring, Maryland. The FDA is seeking to identify capable small business sources to determine the availability and capability of small businesses equipped to provide the required products. The contractor shall provide and deliver twenty, six to eight-month-old, Bordetella-free, unvaccinated baboons. The baboons will be used for pertussis infection and vaccination studies. • The baboons must be delivered to CBER in one shipment. • The vendor will draw blood and perform nasopharyngeal washes prior to shipment. • All baboons shall be examined by a licensed veterinarian and found to be in good health prior to shipping. • The vendor will coordinate with USDA-licensed carriers and the CBER division of veterinary services for the delivery of baboons into quarantine at the CBER primate facility. • The contractor shall maintain liaison with carrier personnel to ensure the animals receive proper care in accordance with USDA standards and guidelines during transit.